Biosensing nanodevice to revolutionize health screenings

March 25, 2008

One day soon a biosensing nanodevice developed by Arizona State University researcher Wayne Frasch may eliminate long lines at airport security checkpoints and revolutionize health screenings for diseases like anthrax, cancer and antibiotic resistant Staphylococcus aureus (MRSA).

Even more incredible than the device itself, is that it is based on the world’s tiniest rotary motor: a biological engine measured on the order of molecules.

Frasch works with the enzyme F1-adenosine triphosphatase, better known as F1- ATPase. This enzyme, only 10 to 12 nanometers in diameter, has an axle that spins and produces torque. This tiny wonder is part of a complex of proteins key to creating energy in all living things, including photosynthesis in plants. F1-ATPase breaks down adenosine triphosphate (ATP) to adenosine diphospahte (ADP), releasing energy. Previous studies of its structure and characteristics have been the source of two Nobel Prizes awarded in 1979 and 1997.

It was through his own detailed study of the rotational mechanism of the F1-ATPase, which operates like a three-cylinder Mazda rotary motor, that Frasch conceived of a way to take this tiny biological powerhouse and couple it with science applications outside of the human body.

An article authored by Frasch and his colleagues in the ASU School of Life Sciences details the technology that would allow this. Their publication “Single-molecule detection of DNA via sequence-specific links between F1-ATPase motors and gold nanorod sensors” was recently published in the journal Lab on a Chip, and featured in the online journal Chemical Biology produced by the Royal Society of Chemistry.

What Frasch and his colleagues show is that the enzyme can be armed with an optical probe (gold nanorod) and manipulated to emit a signal when it detects a single molecule of target DNA. This is achieved by anchoring a quiescent F1-ATPase motor to a surface. A single strand of a reference biotinylated DNA molecule is then attached to its axle. The marker protein, biotin, on the DNA is known to bind specifically and tightly to the glycoprotein avidin, so an avidin-coated gold nanorod is then added. The avidin-nanorod attaches to the biotinylated DNA strand and forms a stable complex.

When a test solution containing a target piece of DNA is added, this DNA binds to the single complementary reference strand attached to the F1-ATPase. The DNA complex, suspended between the nanorod and the axle, forms a stiff bridge. Once ATP is added to the test solution, the F1-ATPase axle spins, and with it, the attached (now double-stranded) DNA and nanorod. The whirling nano-sized device emits a pulsing red signal that can then be detected with a microscope.

According to Frasch, the rotation discriminates fully assembled nanodevices from nonspecifically bound nanorods, resulting in a sensitivity limit of one zeptomole (600 molecules). Simply put, if it’s not moving and flashing, it simply isn’t relevant.

Moreover, Frasch says, “Studies with the F1-ATPase in my laboratory show that since it can detect single DNA molecules, it far exceeds the detection limits of conventional PCR [polymerase chain reaction] technology.”

Such a detection instrument based on the F1-ATPase enzyme would also be “faster and more portable,” he adds.

With support from Science Foundation Arizona (SFAz), Frasch will transfer his work from the bench to biotech, through establishment of a local company that utilizes the nano-sized F1-ATPase to produce a DNA detection instrument.

A prototype of the DNA detector is already in development. It is roughly the size of a small tissue box. Sampling would be as simple as taking a swab from an infected wound or a piece of baggage, dissolving it in a solution and placing a drop on a slide bearing reference F1-ATPases and their nanorods. Once in the instrument, red blinking signals emitted by rotating nanorods would let a computer know there’s trouble, literally, in a flash.

SFAz funding has also enabled Frasch to extend the method to do protein detection at the single molecule level. This is novel because, unlike DNA, proteins can not be amplified artificially to improve the chances of detection.

“Rapid and sensitive biosensing of nucleic acids and proteins is vital for the identification of pathogenic agents of biomedical and bioterrorist importance,” notes Frasch, who is also with the Center for Bioenergy and Photosynthesis in the College of Liberal Arts and Sciences. “It also provides a new avenue through which to analyze genotypes and forensic evidence.”

Source: Arizona State University


   
Rate this story - 4.4 /5 (8 votes)


March 25, 2008 all stories

Comments: 0

4.4 /5 (8 votes)

  • hide
  • Related Stories

  • ASU professor to explore DNA based computing
    created Oct 19, 2005 | popularity not rated yet | comments 0
  • Low forms of cyclin E reduce breast cancer drug's effectiveness
    created 3 minutes ago | popularity not rated yet | comments 0
  • Enhancing arrest of cell growth to treat cancer in mice
    created 18 hours ago | popularity not rated yet | comments 0
  • Ethics debate over blood from newborn safety tests
    created 18 hours ago | popularity not rated yet | comments 0
  • Turkeys domesticated not once, but twice
    created Feb 08, 2010 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

  • Sleeping habits and the risk of cancer
    created Feb 08, 2010
  • Pressure in chambers of the heart
    created Feb 07, 2010
  • Primordial soup canned?
    created Feb 07, 2010
  • Where on the r/K selection theory scale do social insects like ants and bees fall?
    created Feb 06, 2010
  • Testosterone levels and Fighting
    created Feb 05, 2010
  • Evolution Simulator
    created Feb 04, 2010
  • More from Physics Forums - Biology

Other News

Scientists discover novel materials approach to fighting cancer (w/ Video)

Nanotechnology / Bio & Medicine

created 20 hours ago | popularity 4.7 / 5 (6) | comments 0 | with audio podcast

(PhysOrg.com) -- Scientists from the U.S. Department of Energy's Argonne National Laboratory and the University of Chicago Medical Center are shaking up the world of materials science and cancer research on the cover of the ...


Spray-on liquid glass

Spray-on liquid glass is about to revolutionize almost everything

Nanotechnology / Nanomaterials

created Feb 02, 2010 | popularity 4.7 / 5 (233) | comments 91 | with audio podcast report

(PhysOrg.com) -- Spray-on liquid glass is transparent, non-toxic, and can protect virtually any surface against almost any damage from hazards such as water, UV radiation, dirt, heat, and bacterial infections. ...


IBM Scientists Demonstrate World's Fastest Graphene Transistor

IBM Scientists Demonstrate World's Fastest Graphene Transistor

Nanotechnology / Nanophysics

created Feb 05, 2010 | popularity 4.9 / 5 (38) | comments 23 | with audio podcast

(PhysOrg.com) -- In a just-published paper in the magazine Science, IBM researchers demonstrated a radio-frequency graphene transistor with the highest cut-off frequency achieved so far for any graphene device ...


Conductive eTextiles: Stanford finds a new use for cloth

Conductive eTextiles: Researchers move from making batteries from paper to making batteries from cloth

Nanotechnology / Nanomaterials

created Feb 05, 2010 | popularity 4.3 / 5 (7) | comments 4 | with audio podcast

(PhysOrg.com) -- Stanford researchers have moved from making batteries from paper to making batteries from cloth. Your-T-shirt could become a lighted, moving display.


Carbon Based Chips May One Day Replace Silicon Transistors

Carbon Based Chips May One Day Replace Silicon Transistors

Nanotechnology / Nanomaterials

created Feb 03, 2010 | popularity 4.7 / 5 (17) | comments 3 | with audio podcast weblog

(PhysOrg.com) -- IBM researchers are hopeful that, over the next decade, silicon-based transistors will be replaced by carbon-based transistors. IBM has already laid out the ground work for carbon-based transistors.